Complement Factor H Polymorphism and Age-Related Macular Degeneration
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is a common, late-onset, and complex trait with multiple risk factors. Concentrating on a region harboring a locus for AMD on 1q25-31, the ARMD1 locus, we tested single-nucleotide polymorphisms for association with AMD in two independent case-control populations. Significant association ( P = 4.95 × 10 -10 ) was identified within the regulation of complement activation locus and was centered over a tyrosine-402 → histidine-402 protein polymorphism in the gene encoding complement factor H. Possession of at least one histidine at amino acid position 402 increased the risk of AMD 2.7-fold and may account for 50% of the attributable risk of AMD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A major AMD-associated SNP is the Y402H (tyrosine to histidine substitution at amino acid 402) variant of complement factor H (CFH) (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Edwards et al., 2005
In the citing paper
“These SNPs have been reported to be major genetic factors for developing AMD in Caucasians (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Tuo et al., 2006).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Edwards et al., 2005
In the citing paper
“Complement activation playing a major role in AMD pathogenesis is yet another source of inflammation [107-110].”
From Risk mitigation of immunogenicity: a key to personalized retinal gene therapy (2021) · cites this paper as [108]
In the citing paper
“Polymorphisms in human complement regulatory factor H (CFH) predispose individuals to AMD [35, 46, 59]”
From Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain (2022) · cites this paper as [35]
In the citing paper
“Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [4]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Score Tests for Association between Traits and Haplotypes when Linkage Phase Is Ambiguous
Schaid, D. J., Rowland, C. M., Tines, D. E., Jacobson, R. M., & Poland, G. A. (2002) · The American Journal of Human Genetics · doi:10.1086/338688 · Cited by 1,783
The Five-year Incidence and Progression of Age-related Maculopathy
Klein, R., Klein, B. E. K., Jensen, S. C., & Meuer, S. M. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30368-6 · Cited by 1,135
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
The epidemiology of age-related macular degeneration
Klein, R., Peto, T., Bird, A., & Vannewkirk, M. R. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.069 · Cited by 932
Johnson, L. V., Leitner, W. P., Staples, M. K., & Anderson, D. H. (2001) · Experimental Eye Research · doi:10.1006/exer.2001.1094 · Cited by 621
Molecular Biology and Chemistry of the Alternative Pathway of Complement
Müller-Eberhard, H. J., & Schreiber, R. D. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60042-5 · Cited by 408
Seddon, J. M. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.6.785 · Cited by 398
Keenan, T. D., & Chew, E. Y. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.2210 · Cited by 377
Research works printed but not linked: 1
- M. H. Wener, P. R. Daum, G. M. McQuillan, J. Rheumatol.27, 2351 (2000).
Cited by
Items 501–600 of 1,021
Lutein Leads to a Decrease of Factor D Secretion by Cultured Mature Human Adipocytes
Tian, Y., Kijlstra, A., Renes, J., Wabitsch, M., Webers, C. A. B., & Berendschot, T. T. J. M. (2015) · Journal of Ophthalmology · doi:10.1155/2015/430741 · Cited by 93
Cipriani, V., Leung, H.-T., Plagnol, V., Bunce, C., Khan, J. C., Shahid, H., Moore, A. T., Harding, S. P., Bishop, P. N., Hayward, C., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds225 · Cited by 88
Lin, J. B., Tsubota, K., & Apte, R. S. (2016) · npj Aging and Mechanisms of Disease · doi:10.1038/npjamd.2016.3 · Cited by 91
Kurji, K. H., Cui, J. Z., Lin, T., Harriman, D., Prasad, S. S., Kojic, L., & Matsubara, J. A. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-3622 · Cited by 87
Sun, C., Klein, R., & Wong, T. Y. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.03.046 · Cited by 96
Human monogenic disorders — a source of novel drug targets
Brinkman, R. R., Dubé, M., Rouleau, G. A., Orr, A. C., & Samuels, M. E. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1828 · Cited by 93
Ormsby, R. J., Ranganathan, S., Tong, J. C., Griggs, K. M., Dimasi, D. P., Hewitt, A. W., Burdon, K. P., Craig, J. E., Hoh, J., & Gordon, D. L. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1297 · Cited by 87
Ng, T. K., Chen, L. J., Liu, D. T. L., Tam, P. O. S., Chan, W. M., Liu, K., Hu, Y. J., Chong, K. K. L., Lau, C. S. L., Chiang, S. W. Y., et al. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1517 · Cited by 94
Assessing Susceptibility to Age-related Macular Degeneration with Proteomic and Genomic Biomarkers
Gu, J., Pauer, G. J. T., Yue, X., Narendra, U., Sturgill, G. M., Bena, J., Gu, X., Peachey, N. S., Salomon, R. G., Hagstrom, S. A., et al. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800453-mcp200 · Cited by 90
Herbert, A. P., Uhrín, D., Lyon, M., Pangburn, M. K., & Barlow, P. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513611200 · Cited by 88
The Factor H protein family: The switchers of the complement alternative pathway
Lucientes, L., Márquez‐Tirado, B., & de Jorge, E. G. (2022) · Immunological Reviews · doi:10.1111/imr.13166 · Cited by 97
Lommatzsch, A. P., Hermans, P., Müller, K. D., Bornfeld, N., Bird, A. C., & Pauleikhoff, D. (2008) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-007-0749-4 · Cited by 96
Nutritional modulation of age-related macular degeneration
Weikel, K. A., Chiu, C., & Taylor, A. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.03.005 · Cited by 87
“The CFH gene is located on the 1q31–32 chromosome, and its protein negatively regulates the alternative pathway of complement activation.”
BackgroundInfluentialSofat, R., Casas, J. P., Webster, A. R., Bird, A. C., Mann, S. S., Yates, J. R., Moore, A. T., Sepp, T., Cipriani, V., Bunce, C., et al. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyr204 · Cited by 88
Association of complement factor H Y402H gene polymorphism with Alzheimer's disease
Zetterberg, M., Landgren, S., Andersson, M. E., Palmér, M. S., Gustafson, D. R., Skoog, I., Minthon, L., Thelle, D. S., Wallin, A., Bogdanovic, N., et al. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30668 · Cited by 88
“A 1277T>C transition in the CFH gene, resulting in replacement of tyrosine with histidine at position 402 (Y402H) in the protein, increases the risk of AMD two- to fourfold for individuals carrying one 1277C allele (1277TC) and five- to sevenfold for homozygotes (1277CC) [Edwards et al., 2005; Hageman et al., 2005; Ha…”
BackgroundInfluentialVitreomacular traction and exudative age‐related macular degeneration
Schulze, S. D., Hoerle, S., Mennel, S., & Kroll, P. B. (2008) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2008.01210.x · Cited by 94
Bis, J. C., Heckbert, S. R., Smith, N. L., Reiner, A. P., Rice, K. M., Lumley, T., Hindorff, L. A., Marciante, K. D., Enquobahrie, D. A., Monks, S. A., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.09.031 · Cited by 91
Complement Dysregulation and Disease: Insights from Contemporary Genetics
Liszewski, M. K., Java, A., Schramm, E. C., & Atkinson, J. P. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044145 · Cited by 101
Zhao, M., Bai, Y., Xie, W., Shi, X., Li, F., Yang, F., Sun, Y., Huang, L., & Li, X. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125150 · Cited by 88
Lysosomes: regulators of autophagy in the retinal pigmented epithelium
Sinha, D., Valapala, M., Shang, P., Hose, S., Grebe, R., Lutty, G. A., Zigler, J. S., Kaarniranta, K., & Handa, J. T. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2015.08.018 · Cited by 88
“In addition to genetic variants in multiple complement factors being associated with AMD risk (Edwards et al., 2005; Haines et al., 2005; Klein et al., 2005; Yates et al., 2007; Maller et al., 2007; Kondo et al., 2010), the NLRP3 inflammasome has been implicated in geographic atrophy development…”
BackgroundCharbel Issa, P., Victor Chong, N., & Scholl, H. P. N. (2011) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-010-1568-6 · Cited by 87
Aisenbrey, S., Zhang, M., Bacher, D., Yee, J., Brunken, W. J., & Hunter, D. D. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1590 · Cited by 85
Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
Folk, J. C., & Stone, E. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmct1000495 · Cited by 91
Fritsche, L. G., Fleckenstein, M., Fiebig, B. S., Schmitz-Valckenberg, S., Bindewald-Wittich, A., Keilhauer, C. N., Renner, A. B., Mackensen, F., Mößner, A., Pauleikhoff, D., et al. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-8785 · Cited by 88
Cao, S., Ko, A., Partanen, M., Pakzad-Vaezi, K. L., Merkur, A. B., Albiani, D. A., Kirker, A. W., Wang, A., Cui, J. Z., Forooghian, F., et al. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.08.003 · Cited by 98
Function and regulation of the complement system in cardiovascular diseases
Oksjoki, R. K., Kovanen, P. T., Meri, S., & Pentikäinen, M. O. (2007) · Frontiers in bioscience · doi:10.2741/2419 · Cited by 101
“Recent studies have posed the question of whether the Y402H polymorphism of the factor H gene, which locates within the binding site for heparin and Creactive protein and plays a major role in age-related macular degeneration (44-46), might also play a role in atherothrombotic events.”
BackgroundCackett, P., Wong, T. Y., Aung, T., Saw, S.-M., Tay, W. T., Rochtchina, E., Mitchell, P., & Wang, J. J. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.06.026 · Cited by 87
Self‐nonself discrimination by the complement system
Meri, S. (2016) · FEBS Letters · doi:10.1002/1873-3468.12284 · Cited by 87
Lipécz, Á., Miller, L. R., Kovács, I., Czakó, C. N., Csípő, T., Baffi, J., Csiszár, A., Tarantini, S., Ungvari, Z. I., Yabluchanskiy, A., et al. (2019) · GeroScience · doi:10.1007/s11357-019-00138-3 · Cited by 94
Wegscheider, B. J., Weger, M., Renner, W., Steinbrugger, I., März, W., Mossböck, G., Temmel, W., El‐Shabrawi, Y., Schmut, O., Jahrbacher, R., et al. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.07.048 · Cited by 93
Complement Factor H: Spatial and Temporal Expression and Localization in the Eye
Mandal, N. A., & Ayyagari, R. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1655 · Cited by 85
“The role of inflammation in the pathogenesis of AMD is well documented,27,28 and the association of AMD with members of the complement system, C-reactive protein (CRP), factor B (BF), complement component 2 (C2), and CFH has been reported.18,20,22,29,30 Smoking, which increases inflammation, is a potent risk factor fo…”
BackgroundInfluentialGotoh, N., Nakanishi, H., Hayashi, H., Yamada, R., Otani, A., Tsujikawa, A., Yamashiro, K., Tamura, H., Saito, M., Saito, K., et al. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.12.036 · Cited by 87
Seddon, J. M. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-23544 · Cited by 93
Yoon, K. D., Yamamoto, K., Ueda, K., Zhou, J., & Sparrow, J. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041309 · Cited by 88
Clark, S. J., Bishop, P. N., & Day, A. J. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381342 · Cited by 84
Towards a complete resolution of the genetic architecture of disease
Singleton, A. B., Hardy, J., Traynor, B. J., & Houlden, H. (2010) · Trends in Genetics · doi:10.1016/j.tig.2010.07.004 · Cited by 86
Inflammation and the pathogenesis of age-related macular degeneration
Augustin, A. J., & Kirchhof, J. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902942322 · Cited by 83
“Such polymorphisms are known to increase the risk of AMD by several fold [14-17].”
BackgroundKondo, N., Honda, S., Ishibashi, K., Tsukahara, Y., & Negi, A. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1145 · Cited by 88
Complement factor H and the hemolytic uremic syndrome
Atkinson, J. P., & Goodship, T. H. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070664 · Cited by 85
Local complement activation in aqueous humor in patients with age-related macular degeneration
Schick, T., Steinhauer, M., Aslanidis, A., Altay, L., Karlstetter, M., Langmann, T., Kirschfink, M., & Fauser, S. (2017) · Eye · doi:10.1038/eye.2016.328 · Cited by 92
Kaur, I., Hussain, A., Hussain, N., Das, T., Pathangay, A., Mathai, A., Hussain, A., Nutheti, R., Nirmalan, P. K., & Chakrabarti, S. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1430 · Cited by 84
“Tyr402His (T>C) SNP Present Study Edwards et al.(22) Haines et al.”
BackgroundInfluentialToll-like receptor polymorphisms and age-related macular degeneration
Edwards, A. O., Chen, D., Fridley, B. L., James, K. M., Wu, Y., Abecasis, G., Swaroop, A., Othman, M., Branham, K., Iyengar, S. K., et al. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1378 · Cited by 84
“Detailed methods have been published.(2) Genotyping on the Michigan and FARMS cohorts was performed according to previously described methods.”
MethodSelf-citationThe Role of Complement Factor H in Age-related Macular Degeneration: A Review
Donoso, L. A., Vrabec, T. R., & Kuivaniemi, H. (2010) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2009.11.001 · Cited by 92
Brantley, M. A., Edelstein, S. L., King, J. M., Plotzke, M. R., Apte, R. S., Kymes, S. M., & Shiels, A. (2008) · Eye · doi:10.1038/eye.2008.28 · Cited by 89
Sheffield, V. C., & Stone, E. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1012354 · Cited by 92
Complement Factor H Polymorphism and Age-Related Macular Degeneration
Eagle, R. C. (2006) · Yearbook of Ophthalmology · doi:10.1016/s0084-392x(08)70395-2 · Cited by 84
Loyet, K. M., DeForge, L. E., Katschke, K. J., Diehl, L., Graham, R. R., Pao, L., Sturgeon, L., Lewin-Koh, S.-C., Hollyfield, J. G., & van Lookeren Campagne, M. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-9587 · Cited by 80
Thambisetty, M., Hye, A., Foy, C., Daly, E., Glover, A., Cooper, A., Simmons, A., Murphy, D., & Lovestone, S. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0006-8 · Cited by 87
“Recently, a polymorphism in the gene encoding CFH has been strongly associated with age-related macular degeneration (AMD), a condition that shares some pathological features with AD [15].”
BackgroundProgression of Geographic Atrophy and Genotype in Age-Related Macular Degeneration
Klein, M. L., Ferris, F. L., Francis, P. J., Lindblad, A. S., Chew, E. Y., Hamon, S. C., & Ott, J. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.12.012 · Cited by 83
Comparative Functional Evolution of Human and Mouse CR1 and CR2,
Jacobson, A. C., & Weis, J. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.2953 · Cited by 82
Current therapeutic developments in atrophic age-related macular degeneration
Hanus, J., Zhao, F., & Wang, S. (2015) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2015-306972 · Cited by 90
Zinc Nutrition and Inflammation in the Aging Retina
Gilbert, R. M., Pető, T., Lengyel, I., & Emri, E. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201801049 · Cited by 88
“CFH, and its Tyr402 mutant form, is possibly of most interest in relation to zinc, sub-RPE deposit formation and AMD [202-206].”
BackgroundHijacking Factor H for Complement Immune Evasion
Moore, S. R., Menon, S. S., Cortes, C., & Ferreira, V. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.602277 · Cited by 83
Chen, Y. (2011) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.10 · Cited by 92
Trait Components Provide Tools to Dissect the Genetic Susceptibility of Migraine
Anttila, V., Kallela, M., Oswell, G., Kaunisto, M. A., Nyholt, D. R., Hämäläinen, E., Havanka, H., Ilmavirta, M., Terwilliger, J. D., Sobel, E. M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/504814 · Cited by 96
Goverdhan, S. V., Hannan, S., Newsom, R. B., Luff, A. J., Griffiths, H., & Lotery, A. J. (2008) · Eye · doi:10.1038/sj.eye.6702830 · Cited by 83
Defective lipid transport and biosynthesis in recessive and dominant Stargardt macular degeneration
Molday, R. S., & Zhang, K. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.07.002 · Cited by 82
Multilocus analysis of age-related macular degeneration
Bergeron-Sawitzke, J., Gold, B., Olsh, A., Schlotterbeck, S., Lemon, K., Visvanathan, K., Allikmets, R., & Dean, M. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.23 · Cited by 82
Polypoidal Choroidal Vasculopathy: Clinical Features and Genetic Predisposition
Honda, S., Matsumiya, W., & Negi, A. (2013) · Ophthalmologica · doi:10.1159/000355488 · Cited by 82
Mitochondrial dysfunction in age-related macular degeneration: melatonin as a potential treatment
Mehrzadi, S., Hemati, K., Reiter, R. J., & Hosseinzadeh, A. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1737015 · Cited by 86
Wang, J., Ohno-Matsui, K., Yoshida, T., Kojima, A., Shimada, N., Nakahama, K.-I., Safranova, O., Iwata, N., Saido, T. C., Mochizuki, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.712 · Cited by 80
Kam, J. H., Lenassi, E., Malik, T. H., Pickering, M. C., & Jeffery, G. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.04.008 · Cited by 87
A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci
Singleton, A., & Hardy, J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr358 · Cited by 83
Risk Factors for Five-Year Incident Age-related Macular Degeneration: The Reykjavik Eye Study
Arnarsson, Á. M., Sverrisson, T., Stefánsson, E., Sigurðsson, H., Sasaki, H., Sasaki, K., & Jónasson, F. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.04.015 · Cited by 106
Nischler, C., Oberkofler, H., Ortner, C., Paikl, D., Riha, W., Lang, N., Patsch, W., & Egger, S. F. (2011) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2010.02080.x · Cited by 81
“…10.1111/j.1755-3768.2010.02080.x e344 important genetic risk factors for AMD in North American and European population (Conley et al. 2005; Edwards et al. 2005; Haddad et al. 2006; Hageman et al. 2005; Haines et al. 2005; Klein et al. 2005; Rivera et al. 2005; Zareparsi et al. 2005).”
BackgroundInfluentialSobrin, L., Ripke, S., Yu, Y., Fagerness, J. A., Bhangale, T., Tan, P. L., Souied, E. H., Buitendijk, G. H. S., Merriam, J. E., Richardson, A. J., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.03.014 · Cited by 88
C-reactive Protein Level and Risk of Aging Macula Disorder: The Rotterdam Study
Boekhoorn, S. S. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.10.1396 · Cited by 78
Genetics of Immunological and Inflammatory Components in Age-related Macular Degeneration
Tuo, J., Grob, S., Zhang, K., & Chan, C.-C. (2012) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2011.628432 · Cited by 80
Macrophages in neovascular age-related macular degeneration: friends or foes?
Skeie, J. M., & Mullins, R. F. (2009) · Eye · doi:10.1038/eye.2008.206 · Cited by 78
Hong, T., Tan, A. G., Mitchell, P. L. R., & Wang, J. J. (2011) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2010.08.007 · Cited by 86
Identification of anti-retinal antibodies in patients with age-related macular degeneration
Morohoshi, K., Ohbayashi, M., Patel, N., Chong, V. N., Bird, A. C., & Ono, S. J. (2012) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2012.03.007 · Cited by 85
Lipids and Age-related Macular Degeneration
Kishan, A. U., Modjtahedi, B. S., Martins, E. N., Modjtahedi, S. P., & Morse, L. S. (2011) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2010.08.008 · Cited by 86
Production of biologically active complement factor H in therapeutically useful quantities
Schmidt, C. Q., Slingsby, F. C., Richards, A., & Barlow, P. N. (2011) · Protein Expression and Purification · doi:10.1016/j.pep.2010.12.002 · Cited by 81
Wang, J. J., Rochtchina, E., Smith, W., Klein, R., Klein, B. E. K., Joshi, T., Sivakumaran, T. A., Iyengar, S., & Mitchell, P. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn358 · Cited by 79
Effects of smoking on ocular health
Galor, A., & Lee, D. J. (2011) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e32834bbe7a · Cited by 82
Schaumberg, D. A. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.3.300 · Cited by 79
McFadyen, J. D., Zeller, J., Potempa, L. A., Pietersz, G. A., Eisenhardt, S. U., & Peter, K. (2020) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-41769-7_20 · Cited by 84
Reduced secretion of fibulin 5 in age-related macular degeneration and cutis laxa
Lotery, A. J., Baas, D., Ridley, C., Jones, R. P. O., Klaver, C. C. W., Stone, E., Nakamura, T., Luff, A., Griffiths, H., Wang, T., et al. (2006) · Human Mutation · doi:10.1002/humu.20344 · Cited by 78
“Sequence changes in the FBLN5, complement factor H, human leukocyte antigen (HLA), and perhaps the toll-like receptor 4 genes have all been associated with AMD [6-12].”
Heritability of Macular Pigment: A Twin Study
Liew, S. H. M., Gilbert, C. E., Spector, T. D., Mellerio, J., Marshall, J., Kuijk, F. J. V., Beatty, S., Fitzke, F. W., & Hammond, C. J. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0519 · Cited by 85
“The recent evidence that a common variant in the complement factor H (CFH) gene is strongly associated with ARMD highlights the complex integration of genetic and environmental factors.(28,58) Clearly, further work is needed, to determine whether there is any relationship between CFH allelic status and MP optical dens…”
BackgroundAMD and the alternative complement pathway: genetics and functional implications
Tan, P. L., Bowes Rickman, C., & Katsanis, N. (2016) · Human Genomics · doi:10.1186/s40246-016-0079-x · Cited by 79
“Remarkably, modest GWAS analysis on 96 cases and 50 controls yielded a genome-wide significant signal (P < 10) on 1q32 of a common single nucleotide polymorphism (SNP) on a gene encoding CFH that revealed a polymorphism in linkage disequilibrium, Y402H, that has proven to be a common, predisposing allele that confers…”
BackgroundSobrin, L., Reynolds, R., Yu, Y., Fagerness, J., Leveziel, N., Bernstein, P. S., Souied, E. H., Daly, M. J., & Seddon, J. M. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.08.015 · Cited by 78
Association of Genetic Variants with Polypoidal Choroidal Vasculopathy
Ma, L., Li, Z., Liu, K., Rong, S. S., Brelen, M. E., Young, A. L., Kumaramanickavel, G., Pang, C. P., Chen, H., & Chen, L. J. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.05.012 · Cited by 81
Complement in age-related macular degeneration: a focus on function
Bradley, D., Zipfel, P. F., & Hughes, A. E. (2011) · Eye · doi:10.1038/eye.2011.37 · Cited by 85
Bernig, T., & Chanock, S. J. (2006) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.6.3.319 · Cited by 81
Emerson, M., & Lauer, A. K. (2007) · BioDrugs · doi:10.2165/00063030-200721040-00005 · Cited by 86
Regulated secretion of complement factor H by RPE and its role in RPE migration
Kim, Y. H., He, S., Kase, S., Kitamura, M., Ryan, S. J., & Hinton, D. R. (2009) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-009-1049-y · Cited by 76
Genetic variation and association mapping for 12 agronomic traits in indica rice
Lu, Q., Zhang, M., Niu, X., Shan, W., Xu, Q. J., Feng, Y., Wang, C., Deng, H., Yuan, X., Yu, H., et al. (2015) · BMC Genomics · doi:10.1186/s12864-015-2245-2 · Cited by 88
“In the past few years, GWASs were successfully applied to the dissection of complex traits in humans [24] and animals [25].”
BackgroundComplex genetics of complex traits: the case of primary open‐angle glaucoma
Hewitt, A. W., Craig, J. E., & Mackey, D. A. (2006) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2006.01268.x · Cited by 84
Risk Assessment Model for Development of Advanced Age-Related Macular Degeneration
Klein, M. L., Francis, P. J., Ferris, F. L., Hamon, S., & Clemons, T. E. (2011) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.216 · Cited by 85
“Risk of developing advanced AMD within _____ years (1-10)”
BackgroundCollier, R. J., Wang, Y., Smith, S. S., Martin, E., Ornberg, R., Rhoades, K., & Romano, C. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6418 · Cited by 78
A missense variant in FGD6 confers increased risk of polypoidal choroidal vasculopathy
Huang, L., Zhang, H., Cheng, C., Wen, F., Tam, P. O. S., Zhao, P., Chen, H., Li, Z., Chen, L., Tai, Z., et al. (2016) · Nature Genetics · doi:10.1038/ng.3546 · Cited by 80
Wu, X., Hutson, I., Akk, A. M., Mascharak, S., Pham, C. T. N., Hourcade, D. E., Brown, R. J., Atkinson, J. P., & Harris, C. A. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701668 · Cited by 81
Promising new treatments for neovascular age-related macular degeneration
Michels, S., Schmidt-Erfurth, U. M., & Rosenfeld, P. J. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.7.779 · Cited by 80
“Recent findings suggest that complement factor H plays an important role in AMD, further supporting the argument that inflammation contributes to AMD and certain polymorphisms of complement factor H put individuals at risk of developing AMD [33-35].”
BackgroundImmunology Taught by Human Genetics
Casanova, J.-L., Abel, L., & Quintana-Murci, L. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.019968 · Cited by 69
“The same result was however obtained following a linkage approach (Edwards et al. 2005; Haines et al. 2005).”
Antiangiogenic Therapy for Ischemic Retinopathies
Al-Latayfeh, M., Silva, P. S., Sun, J. K., & Aiello, L. P. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006411 · Cited by 83
“Genetic variations in the factor H gene are highly associated with an increased risk of AMD (Edwards et al. 2005).”
BackgroundHDL Cholesterol and Non-Cardiovascular Disease: A Narrative Review
Kjeldsen, E. W., Nordestgaard, L. T., & Frikke‐Schmidt, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094547 · Cited by 81
Francis, P. J., Schultz, D. W., Hamon, S., Ott, J., Weleber, R. G., & Klein, M. L. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001197 · Cited by 74
Kondo, N., Honda, S., Kuno, S., & Negi, A. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.11.011 · Cited by 78
Transformation of the proteasome with age‐related macular degeneration
Ethen, C. M., Hussong, S. A., Reilly, C., Feng, X., Olsen, T. W., & Ferrington, D. A. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.01.061 · Cited by 77
Age-related macular degeneration: Complement in action
van Lookeren Campagne, M., Strauss, E. C., & Yaspan, B. L. (2016) · Immunobiology · doi:10.1016/j.imbio.2015.11.007 · Cited by 76
Metadata
- Authors
- Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A.
- Affiliations
- Boston University (US)
- Corresponding author
- Edwards, Albert O.
- Venue
- Science
- Published
- 2005-04-15
- Volume
- 308
- Issue
- 5720
- Pages
- 421-424
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3145351529
- Cited by
- 2,449
- References
- 30
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 51 · 2023: 48 · 2022: 78 · 2021: 105 · 2020: 73 · 2019: 52 · 2018: 81 · 2017: 65 · 2016: 89 · 2015: 120 · 2014: 141 · 2013: 146 · 2012: 166
- FWCI
- 195.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (EY014467, R01EY014467)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- age-related macular degeneration, complement factor H, CFH Y402H polymorphism, single nucleotide polymorphisms, genetic association, disease risk
- MeSH terms
- Aged, Alleles, Chromosomes, Human, Pair 1, Complement Activation, Female, Gene Frequency, Multigene Family, Genotype, Haplotypes, Histidine, Homozygote, Humans, Macular Degeneration, Male, Middle Aged, Risk Factors, Tyrosine, Genetic Variation, Linkage Disequilibrium, Case-Control Studies, Complement Factor H, Amino Acid Substitution, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.